Drugs and Devices

FDA approves treatment for opioid-induced constipation

On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares